FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q28239742> ?p ?o ?g. }

• Q28239742 description "2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
• Q28239742 description "2009 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
• Q28239742 description "2009 ഏപ്രില്‍ 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
• Q28239742 description "artículu científicu espublizáu en 2009" @default.
• Q28239742 description "im April 2009 veröffentlichter wissenschaftlicher Artikel" @default.
• Q28239742 description "scientific article (publication date: April 2009)" @default.
• Q28239742 description "vedecký článok (publikovaný 2009-04)" @default.
• Q28239742 description "vědecký článek publikovaný v roce 2009" @default.
• Q28239742 description "wetenschappelijk artikel (gepubliceerd in 2009-04)" @default.
• Q28239742 description "наукова стаття, опублікована у квітні 2009" @default.
• Q28239742 description "مقالة علمية (نشرت في أبريل 2009)" @default.
• Q28239742 name "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 name "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 name "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 type Item @default.
• Q28239742 label "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 label "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 label "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 prefLabel "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 prefLabel "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 prefLabel "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 P10863 Q28239742-8CFC11D4-64CB-4B5F-A6BA-A3688D9DFBF4 @default.
• Q28239742 P1433 Q28239742-BC11CCC2-8D73-4F8F-9C21-2056A10E1937 @default.
• Q28239742 P1476 Q28239742-B85149C4-60BE-4CDA-88A4-49C2E544977B @default.
• Q28239742 P2093 Q28239742-10C18DD7-A3DA-45DE-87A2-94297A355501 @default.
• Q28239742 P2093 Q28239742-16F129E3-EA51-49C4-A419-463E9CCBC857 @default.
• Q28239742 P2093 Q28239742-317B989C-A728-43F1-8C02-0EF9E223C4B8 @default.
• Q28239742 P2093 Q28239742-4E6F0979-B702-4448-87E2-3EFC4F8EF24B @default.
• Q28239742 P2093 Q28239742-62AE34C1-4585-42E8-91A5-F2686B512EBC @default.
• Q28239742 P2093 Q28239742-757A4BF8-13C8-4EBB-82EF-0B529D5BF04C @default.
• Q28239742 P2093 Q28239742-96E5CD4A-E467-44DB-A804-AF6541F079B4 @default.
• Q28239742 P2093 Q28239742-9732B42B-B5C8-4CA2-99A1-A4DFE6CBD4EA @default.
• Q28239742 P2860 Q28239742-0009D286-A8B0-47A3-8253-510D37711391 @default.
• Q28239742 P2860 Q28239742-02460BDE-F513-4428-BDFE-95831BEE3336 @default.
• Q28239742 P2860 Q28239742-05EAC03C-CB81-4C92-B6E7-3E650CB09212 @default.
• Q28239742 P2860 Q28239742-08D206C6-95D7-407A-89C9-03A97B53E537 @default.
• Q28239742 P2860 Q28239742-0F422D5F-3874-4FB1-B329-F8FBF248743A @default.
• Q28239742 P2860 Q28239742-129B6834-4CD0-4117-8899-8FF4856D5F5D @default.
• Q28239742 P2860 Q28239742-1527D6C7-1AEB-42F4-A84D-7EAE3E32C687 @default.
• Q28239742 P2860 Q28239742-178AF2A5-346B-4508-BBFB-557B2947283A @default.
• Q28239742 P2860 Q28239742-201606DE-BEA5-461C-BBAF-709053AC4941 @default.
• Q28239742 P2860 Q28239742-36DD0018-5987-4F8B-9311-1BA339188B06 @default.
• Q28239742 P2860 Q28239742-3CBC40A5-154E-4AFC-8377-191E96254221 @default.
• Q28239742 P2860 Q28239742-4DC4E637-6572-4688-BB30-CEA66909722F @default.
• Q28239742 P2860 Q28239742-512F2200-E12D-4ECF-B483-ECD1A6B39206 @default.
• Q28239742 P2860 Q28239742-51C9B7E9-FC79-4E31-B9BE-25364CEF06AC @default.
• Q28239742 P2860 Q28239742-51F6C3AB-AEBC-4AD5-805D-317556BA63DD @default.
• Q28239742 P2860 Q28239742-5FEBCE0A-55E7-489B-B2F0-0CACC1007FD4 @default.
• Q28239742 P2860 Q28239742-699DA9A9-AEDA-413D-8C3D-5CFCA9B56AB7 @default.
• Q28239742 P2860 Q28239742-76B74274-1D48-4BD6-96E5-9C01B3E1E40A @default.
• Q28239742 P2860 Q28239742-7E37E87C-A361-49D2-B545-14C78F03B22E @default.
• Q28239742 P2860 Q28239742-7FD86C7B-B919-4BBA-947C-54C74F93AB29 @default.
• Q28239742 P2860 Q28239742-80BD2C19-8252-4787-BC43-893752654C78 @default.
• Q28239742 P2860 Q28239742-8390B573-AE00-4888-B603-1117CE242BCD @default.
• Q28239742 P2860 Q28239742-878B0A15-B1CD-425F-9CD0-1BBF54E8CF1A @default.
• Q28239742 P2860 Q28239742-8C68058A-6F9D-4458-A094-9F5985F29BE9 @default.
• Q28239742 P2860 Q28239742-8E621CD4-6A37-4D94-A17A-29EA4D84CA21 @default.
• Q28239742 P2860 Q28239742-8F45B0E9-A98A-429B-ADF5-0DD2C9403E7D @default.
• Q28239742 P2860 Q28239742-92D1D411-20D4-4381-86C4-7722537DDEF8 @default.
• Q28239742 P2860 Q28239742-93092E7D-E9EA-49DE-A02E-09BB7BBBF17C @default.
• Q28239742 P2860 Q28239742-9D49A116-FDF2-4722-BCD7-3B9AC32267A8 @default.
• Q28239742 P2860 Q28239742-9DF87094-042F-4C1A-ACB6-7D5158AA7D20 @default.
• Q28239742 P2860 Q28239742-C5507506-AD71-4554-B178-2C4ECDD9A87B @default.
• Q28239742 P2860 Q28239742-C55421F7-B2D5-44E4-9BD5-9EA6A64CCCFD @default.
• Q28239742 P2860 Q28239742-C58E5D1C-3150-41E8-9249-3D3017C3E112 @default.
• Q28239742 P2860 Q28239742-C952328B-B996-4C3E-8880-4D90729B48A3 @default.
• Q28239742 P2860 Q28239742-CA7E6FC6-44B5-4E43-8A2C-D9925020B758 @default.
• Q28239742 P2860 Q28239742-CCD53020-E090-4888-9727-207CA951549F @default.
• Q28239742 P2860 Q28239742-CEAD98AD-F662-4772-9FB9-FC85C25AB411 @default.
• Q28239742 P2860 Q28239742-F5F0C583-8507-4F5E-BB27-A399E613C798 @default.
• Q28239742 P2860 Q28239742-F80CC6E1-D422-481D-B3C4-7306557B3CEF @default.
• Q28239742 P2860 Q28239742-FA2A6B6A-918C-4E8F-9877-3822AE9B6DC6 @default.
• Q28239742 P304 Q28239742-1D9EB8AF-06C6-4164-B463-F4993FA001DC @default.
• Q28239742 P31 Q28239742-D551F501-D366-4EB0-971B-419A90C36870 @default.
• Q28239742 P356 Q28239742-611BA8F5-2D48-4805-A597-E51258492029 @default.
• Q28239742 P407 Q28239742-1E07BB07-0AFF-40AB-842B-93EB02246946 @default.
• Q28239742 P433 Q28239742-1A218AA6-CDE2-454C-8AD2-620CE630BAE1 @default.
• Q28239742 P478 Q28239742-7B8B97CD-7A0A-4BB9-870B-96C4210AB6EE @default.
• Q28239742 P577 Q28239742-EFE4DA57-3DBF-4E64-A018-FE5D024461A4 @default.
• Q28239742 P5875 Q28239742-AAED00E5-D030-43C8-8623-8393E660D2F3 @default.
• Q28239742 P6179 Q28239742-B6CA4278-9E47-41FA-AD5C-A4FB8BFB1C51 @default.
• Q28239742 P698 Q28239742-4B130177-7DF8-464C-B611-1DF4AA64435D @default.
• Q28239742 P932 Q28239742-82196593-72F7-4EE4-ACC5-9E3D4670D6D2 @default.
• Q28239742 P356 J.NURT.2009.01.001 @default.
• Q28239742 P698 19332332 @default.
• Q28239742 P10863 "10.1016/j.nurt.2009.01.001" @default.
• Q28239742 P1433 Q15716631 @default.
• Q28239742 P1476 "Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models" @default.
• Q28239742 P2093 "Brad R Green" @default.
• Q28239742 P2093 "Brian D Klein" @default.
• Q28239742 P2093 "Erika A Scholl" @default.
• Q28239742 P2093 "Grzegorz Bulaj" @default.
• Q28239742 P2093 "H Steve White" @default.
• Q28239742 P2093 "Liuyin Zhang" @default.
• Q28239742 P2093 "Sean P Flynn" @default.
• Q28239742 P2093 "Timothy H Pruess" @default.
• Q28239742 P2860 Q24531395 @default.
• Q28239742 P2860 Q24564195 @default.
• Q28239742 P2860 Q28145418 @default.
• Q28239742 P2860 Q28236678 @default.

• next